Appendix 4D - Half Yearly Report and Accounts
Filed with ASX · · 19 pages · English
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- 2016 AGM MD and CEO Presentation
- STI Detection Kit Clinical Validation Trial Results
- Open Briefing - Capital Raising and Company Outlook
- Clinical Validation of Sexual Health Detection Kit Commenced
- Completion of $14m capital raising
Later from Genetic Signatures
- GSS Launches Sexually Transmitted Infection (STI) Kit
- Results of Flavivirus Clinical Trial
- Regulatory and Patent approval
- Appendix 4E and 2017 Financial Report
- 2017 AGM Presentation
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures